Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan

Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: comment on two papers

(2015) T. Iba   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Antithrombin or thrombomodulin administration in severe pneumonia patients with sepsis and disseminated intravascular coagulation: reply to two papers

(2015) T. Tagami et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis

(2015) K. Yamakawa et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Supplemental dose of antithrombin use in disseminated intravascular coagulation patients after abdominal sepsis

(2015) Hiroki Matsui et al.   THROMBOSIS AND HAEMOSTASIS

The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation

(2015) Toshiaki Iba et al.   THROMBOSIS RESEARCH

Novel regulators of endothelial barrier function

(2014) Dolly Mehta et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

The Obstacles That Should be Overcome to Develop New Anticoagulants for Severe Sepsis

(2014) Toshiaki Iba   CRITICAL CARE MEDICINE

Protection of glycocalyx decreases platelet adhesion after ischaemia/reperfusion

(2014) Daniel Chappell et al.   EUROPEAN JOURNAL OF ANAESTHESIOLOGY

Recombinant human soluble thrombomodulin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study

(2014) T. Tagami et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Anticoagulant therapy for sepsis-associated disseminated intravascular coagulation: the view from Japan

(2014) T. Iba et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study

(2014) T. Tagami et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The recent time trend of outcomes of disseminated intravascular coagulation in Japan: an observational study based on a national administrative database

(2014) Atsuhiko Murata et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

A Short Contemporary History of Disseminated Intravascular Coagulation

(2014) Tom van der Poll et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

The coagulation system and its function in early immune defense

(2014) Tom van der Poll et al.   THROMBOSIS AND HAEMOSTASIS

Addition of recommendations for the use of recombinant human thrombomodulin to the “Expert consensus for the treatment of disseminated intravascular coagulation in Japan”

(2014) H. Wada et al.   THROMBOSIS RESEARCH

Observational study to compare antithrombin and thrombomodulin for disseminated intravascular coagulation

(2014) Atsuhiko Murata et al.   International Journal of Clinical Pharmacy

Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with HMGB1-mediated TLR2 signalling

(2013) Christine Herzog et al.   CARDIOVASCULAR RESEARCH

Trends in the Incidence and Outcomes of Disseminated Intravascular Coagulation in Critically Ill Patients (2004-2010)

(2013) Balwinder Singh et al.   CHEST

Thrombin Generation Mediators and Markers in Sepsis-Associated Coagulopathy and Their Modulation by Recombinant Thrombomodulin

(2013) Debra Hoppensteadt et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation*

(2013) Jean-Louis Vincent et al.   CRITICAL CARE MEDICINE

Epidemiology of severe sepsis in Japanese intensive care units: A prospective multicenter study

(2013) Hiroshi Ogura et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

A multicenter, prospective evaluation of quality of care and mortality in Japan based on the Surviving Sepsis Campaign guidelines

(2013) Seitaro Fujishima et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines

(2013) H. Wada et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

The anticoagulant therapy for sepsis-associated disseminated intravascular coagulation

(2013) Toshiaki Iba et al.   THROMBOSIS RESEARCH

Protein C anticoagulant and cytoprotective pathways

(2012) John H. Griffin et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Protease-activated receptor-1 cleaved at R46 mediates cytoprotective effects

(2012) R. A. SCHUEPBACH et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: A prospective multicenter survey

(2012) Toshiaki Iba et al.   THROMBOSIS RESEARCH

Diagnosis and treatment of disseminated intravascular coagulation: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)

(2011) Marcello Di Nisio et al.   THROMBOSIS RESEARCH

Guidelines for the diagnosis and management of disseminated intravascular coagulation

(2009) M Levi et al.   BRITISH JOURNAL OF HAEMATOLOGY

Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion

(2009) D. Chappell et al.   CARDIOVASCULAR RESEARCH

Expert consensus for the treatment of disseminated intravascular coagulation in Japan

(2009) Hideo Wada et al.   THROMBOSIS RESEARCH